DJIA 17,598.20 -91.66 -0.52%
NASDAQ 5,115.38 -12.90 -0.25%
S&P 500 2,098.04 -5.80 -0.28%
market minute promo

Geron Corp (NASDAQ: GERN)

company name or ticker

3 Biotech Stocks That Could Double Before 2016

Here is a look at three small-cap biotech stocks with the potential to double within the next six months.

Geron's Second-Line Myelofibrosis Trial Offers Significant EPS Potential

Geron's Much Anticipated Imetelstat Phase 2 Study Grows To 50 Locations And Begins Enrollment

Orphan Drugs Series: Time From ODD To Market Approval

Geron (GERN) Is Today's Dead Cat Bounce Stock

3 Experimental Cancer Drugs Investors Should Be Closely Watching

Meet the drugs our experts believe have shown the most promising results in the race to cure cancer.

Geron (GERN) Highlighted As Weak On High Volume

Premarket Biotech Digest: Geron's Sharp Gain, Bayer Essure AEs, Juno Moves Higher

This Biotech Stock Has Jaw-Dropping Growth Potential

Geron Corp. is small-cap biotech with major growth potential.

Geron Is Ripe For A Short Squeeze

See More Articles...